What is Corbus Pharmaceuticals Holdings, Inc.'s Market Cap?

Corbus Pharmaceuticals Holdings, Inc.'s Market Cap is $204.9M, based on as-reported figures from SEC (XBRL) filings.

What is Corbus Pharmaceuticals Holdings, Inc.'s Net Income (TTM)?

Corbus Pharmaceuticals Holdings, Inc.'s Net Income (TTM) is -$101.9M, based on as-reported figures from SEC (XBRL) filings.

What is Corbus Pharmaceuticals Holdings, Inc.'s EBITDA?

Corbus Pharmaceuticals Holdings, Inc.'s EBITDA is -$106.7M, based on as-reported figures from SEC (XBRL) filings.

What is Corbus Pharmaceuticals Holdings, Inc.'s Diluted EPS (TTM)?

Corbus Pharmaceuticals Holdings, Inc.'s Diluted EPS (TTM) is -5.27, based on as-reported figures from SEC (XBRL) filings.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financial Statements

Corbus Pharmaceuticals Holdings, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0078PJKP8

XNAS · usd

10.60▼ 0.48 (-4.38%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close11.08

Day's Range10.31 – 11.07

52-Week Range7.12 – 20.56

Volume914.2K

Avg Volume481.6K

Share Statistics

Shares Outstanding

Employees36

ExchangeXNAS

Listed2014-10-24

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Corbus Pharmaceuticals Holdings, Inc. (CRBP)

What is Corbus Pharmaceuticals Holdings, Inc.'s Market Cap?: Corbus Pharmaceuticals Holdings, Inc.'s Market Cap is $204.9M, based on as-reported figures from SEC (XBRL) filings.
What is Corbus Pharmaceuticals Holdings, Inc.'s Net Income (TTM)?: Corbus Pharmaceuticals Holdings, Inc.'s Net Income (TTM) is -$101.9M, based on as-reported figures from SEC (XBRL) filings.
What is Corbus Pharmaceuticals Holdings, Inc.'s EBITDA?: Corbus Pharmaceuticals Holdings, Inc.'s EBITDA is -$106.7M, based on as-reported figures from SEC (XBRL) filings.
What is Corbus Pharmaceuticals Holdings, Inc.'s Diluted EPS (TTM)?: Corbus Pharmaceuticals Holdings, Inc.'s Diluted EPS (TTM) is -5.27, based on as-reported figures from SEC (XBRL) filings.